Large Neuronetics (STIM) insider purchase adds 531,000 shares at $1.16

Rhea-AI Filing Summary

Neuronetics, Inc. major shareholder Jorey Chernett reported an open-market purchase of 531,000 shares of common stock at a weighted average price of $1.16 per share. The filing notes the shares were bought in multiple trades between $0.91 and $1.31 per share. Following this transaction, Chernett directly owns 7,516,404 shares of Neuronetics common stock.

Insights

Equity analyst

Large open-market share purchase increases this major holder’s direct stake.

Major shareholder Jorey Chernett executed an open-market purchase of 531,000 Neuronetics shares at a weighted average of $1.16. Open-market buys are discretionary decisions, typically indicating the holder chose to add direct exposure at prevailing prices.

After the transaction, Chernett’s direct holdings total 7,516,404 common shares, according to the filing. The price range of $0.91–$1.31 per share shows the buying occurred across multiple trades rather than a single block, which is common for larger accumulations.

The filing does not reference any derivative positions or a Rule 10b5-1 trading plan, and derivative holdings are not listed in the derivative section. Future company filings may provide additional context on how this larger position fits into overall ownership dynamics.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chernett Jorey

(Last) (First) (Middle)

6222 INDIANWOOD TR.

(Street)

BLOOMFIELD HILLS MICHIGAN 48301

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		P		531,000	A	$1.16(1)	7,516,404	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $0.91 to $1.31, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

	/s/ Jorey Chernett	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Jorey Chernett report in the latest Neuronetics (STIM) Form 4?

Jorey Chernett reported buying 531,000 Neuronetics common shares in the open market at a weighted average of $1.16 per share. This transaction increased his direct holdings to 7,516,404 shares, according to the Form 4 filing.

At what prices did Chernett buy Neuronetics (STIM) stock in this transaction?

The filing shows a weighted average purchase price of $1.16 per share. Individual trades were executed in multiple transactions at prices ranging from $0.91 to $1.31 per share, with all values rounded to the nearest cent.

How many Neuronetics (STIM) shares does Jorey Chernett own after the reported purchase?

After the reported open-market purchase, Jorey Chernett directly owns 7,516,404 shares of Neuronetics common stock. This total includes the newly acquired 531,000 shares, as disclosed in the Form 4’s post-transaction ownership column.

Was the Neuronetics (STIM) insider transaction a buy or a sell?

The reported Neuronetics transaction was a buy. The Form 4 lists transaction code P and describes it as an open-market purchase of 531,000 common shares, rather than a sale or other type of disposition.

Did the Neuronetics (STIM) Form 4 mention multiple trade executions for this purchase?

Yes. The footnote explains the $1.16 price is a weighted average for shares bought in multiple trades. Those trades occurred at prices between $0.91 and $1.31, and detailed breakdowns are available upon request.